{"schema_version":"secwatch.filing_event.v1","accession":"0001174947-25-000234","form_type":"8-K","ticker":"CNMD","cik":"0000816956","company_name":"CONMED Corp","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.424400+00:00","generated_at":"2026-05-26T05:17:23.561884+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CONMED appoints Mark Kaye as director; declares $0.20 quarterly dividend","bullets":["Board expanded to nine; Mark Kaye appointed effective Feb 24, 2025, with Audit and Strategy committee assignments.","Quarterly dividend of $0.20 per share declared, payable April 4, 2025 to holders of record March 14, 2025.","Kaye currently EVP & CFO of Elevance Health; previously CFO of Moody's and senior finance roles at MassMutual and ING.","Kaye received prorated equity grant of 152 RSUs and options on 1,846 shares, vesting in full on Feb 24, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001174947-25-000234","json":"https://secwatch.observer/filing/0001174947-25-000234.json","markdown":"https://secwatch.observer/filing/0001174947-25-000234.md","text":"https://secwatch.observer/filing/0001174947-25-000234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/0001174947-25-000234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/form8k-33666_cnmd.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:17:23.561884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19fc75806e","claim":"Mark Kaye was appointed as Director at CONMED Corp.","evidence_excerpt":"On February 24, 2025, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Mark Kaye as a director effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/0001174947-25-000234-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}